Loading…
Medtronic plc will acquire all outstanding shares of Intersect ENT for $28.25 per share in an all-cash transaction, implying an enterprise value of approximately $1.1 billion.
“This acquisition directly aligns with our commitment to delivering continuous innovation that helps ENT patients.”news.medtronic.com
Summarized from public sources; check the original articles before acting on it.